ObjectiveTo investigate the therapeutic efficacy and economic analysis of ultrafilter concentration in refractory ascites. 研究腹水超滤浓缩腹腔回输治疗难治性腹水的临床疗效并进行经济学评价。
None of these seven patients had refractory ascites after revision or died from end-stage liver disease. 这个病人在修复后无一人产生难治性腹水或死于终末期肝病。